IL1B and major depressive disorder: Although data from both preclinical and healthy volunteer studies with IL-1β as peripheral pharmacological biomarker for P2X7R antagonism seem encouraging, JNJ-54175446’s mood modulating effects are yet to be established in a target patient population such as MDD.